OPEN-SOURCE SCRIPT
已更新 CDC ATR Trailing Stop V2.1 (2013)
CDC ATR Trailing Stop V2.1
The indicator / system was developed a few years ago.
Contains two ATR trailing stop lines, fast and slow.
The slow ATR SL line is the same as the one in a normal ATR trailing stop loss indicator.
The fast one is created to generate buy/sell signals
To use the signals, activate them from the indicator's settings (gear icon next to the indicator's name on the chart) and enable buy / sell arrows.
The system works well in high volatility market.
I personally use this as the faster system in conhunction with my slower MA system to diversify portfolio performance.
The indicator / system was developed a few years ago.
Contains two ATR trailing stop lines, fast and slow.
The slow ATR SL line is the same as the one in a normal ATR trailing stop loss indicator.
The fast one is created to generate buy/sell signals
To use the signals, activate them from the indicator's settings (gear icon next to the indicator's name on the chart) and enable buy / sell arrows.
The system works well in high volatility market.
I personally use this as the faster system in conhunction with my slower MA system to diversify portfolio performance.
發行說明
Added Alert Conditions and Line ID發行說明
Bug fix so it is usable.開源腳本
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
免責聲明
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
開源腳本
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
免責聲明
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.